Skip to main content
. 2019 May 12;294(24):9326–9341. doi: 10.1074/jbc.REV119.006860

Table 2.

Structures of HIV TAR in complex with peptides or proteins

TAR RNA Ligand source Ligand scaffold Method PDB codes Refs.
BIV BIV Tat (68–81) Peptide NMR 1mnb 73
BIV BIV Tat (65–81) Peptide NMR 1biv 75
BIV BIV Tat-derived peptide Cyclic peptide NMR 2a9x 82
BIV JDV Tat ARM Peptide NMR 1zbn 155
EIAV EIAV CycT1-Tat Protein complex X-ray 2w2h 135
HIV-1 Designed Tat mimic L-22 Cyclic peptide NMR 2kdq 70
HIV-2 Lead compound Arginine-pyrimidine tripeptide NMR 2kmj 32
HIV-1 Designed Tat mimic KPZ-41 Cyclic peptide NMR 2kx5 62
HIV-1 L-22 (low population) Cyclic peptide NMR 5j2w 67
HIV-1 HIV-1 Tat (1–49)-SEC Protein complex X-ray 5l1z 68
HIV-1 HIV-1 Tat (1–49)-SEC Protein complex X-ray 6cyt 139
HIV-1 TBP6.7 Lab-evolved protein X-ray 6cmn 77
HIV-2 HIV-1 Tat (44–60) Peptide NMR 6mce 76
HIV-1 Designed Tat mimic JB181 Cyclic peptide NMR 6d2u 63